Research summary, original research, 2024

Radiation Exposure and Protection for (Assumed) Pregnant Interventional Cardiologists and Electrophysiologists

Fetterly KA, Schueler BA, Mihailovic JM, Fiedler JH, Sturchio GM, Cabalka A, et al.. Journal of the Society for Cardiovascular Angiography & Interventions. 2024

Read the original paper

In plain language

In 42 interventional cardiologists and electrophysiologists at one US center, abdominal exposure behind 0.5 mm Pb-equivalent material over 40 weeks was about 0.22 mGy, implying estimated fetal doses well below US and international limits. Sex, height and role did not affect exposure.

At a glance

Type of study
Original research, Dosimetry measurement study
Who was studied
Interventional cardiologists, Electrophysiologists, Trainees
Size
n = 42 cardiologists
Where
United States
Summary based on
the full text

What it found

  • Median 40-week abdominal exposure behind 0.5 mm Pb equivalent material was very low.

    Key figures: 0.22 mGy (90% confidence interval (CI), 0.05-0.83)

  • Estimated fetal dose was well below National Council on Radiation Protection and Measurements (NCRP) (5 mSv) and International Commission on Radiological Protection (ICRP) (1 mSv) limits, and below natural background over 40 weeks.

    Key figures: 0.11 mSv (95th % 0.42 mSv) with 0.5 mm; 0.26 mSv (95th % 1.0 mSv) with 0.25 mm

  • Exposure transmitted through protective material fell with thickness; relative to shoulder, unshielded abdomen was 2.21x and 0.5 mm-shielded abdomen 0.09x.

    Key figures: 0 mm 2.21; 0.25 mm 0.20; 0.35 mm 0.13; 0.5 mm 0.09 (all P < .001)

  • Physician sex, height, role and specialty did not significantly influence abdominal exposure.

    Key figures: sex female vs male 1.16 (0.68-2.00), P = .57

  • Materials from two vendors differed across thicknesses but not at 0.5 mm.

    Key figures: 1.69 (1.15-2.50), P = .01; at 0.5 mm 0.88, P > .999

Limits to keep in mind

Single-center study with dosimeters taped outside garments, mostly non-pregnant participants, and 6-month readings extrapolated to 40 weeks; shield use and positioning were uncontrolled, and fetal dose was estimated rather than measured.

How this summary was made

ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.